When to Discontinue NAC in Acetaminophen Overdose
Discontinue NAC after completing the standard 20-21 hour protocol when the patient meets all of the following criteria: acetaminophen level is undetectable (or <10 mg/L), transaminases (ALT/AST) are normal or declining and below 1000 IU/L, INR is normal, and the patient is asymptomatic without evidence of hepatotoxicity. 1
Standard Treatment Duration
The FDA-approved regimen consists of 300 mg/kg total NAC given over 20-21 hours in either a 2-bag or 3-bag protocol 1. This remains the standard approach supported by ACEP guidelines, which demonstrated no acetaminophen-related mortality when NAC was initiated within 24 hours 2.
Criteria for Safe Discontinuation at 20-21 Hours
Stop NAC when ALL of the following are met:
- Acetaminophen level: Undetectable or <10 mg/L (some protocols use <20 mg/L) 3, 4
- Transaminases: ALT/AST normal (<40 IU/L) or stable/declining if elevated 3, 5
- INR: Normal or acceptable 4
- Clinical status: No signs of hepatotoxicity or encephalopathy 1
The recent NACSTOP 2 trial (2026) demonstrated non-inferiority of stopping NAC at 12-13 hours in highly selected low-risk patients (ALT <40 IU/L at presentation AND at 12 hours, acetaminophen <20 mg/L at 12 hours), with no patients developing hepatotoxicity 3. However, this abbreviated approach should only be used in patients meeting these strict low-risk criteria.
When to EXTEND NAC Beyond 21 Hours
Continue NAC infusions (typically 100 mg/kg over 16 hours, repeated as needed) if ANY of the following persist:
- Detectable acetaminophen levels (>10-20 mg/L) 4
- Rising or persistently elevated transaminases (ALT/AST >1000 IU/L or continuing to rise) 5, 6
- Coagulopathy (elevated INR) 4
- Clinical hepatotoxicity (encephalopathy, jaundice, right upper quadrant pain) 2
- Late presentation (>24 hours post-ingestion) with ongoing toxicity 2, 7
- Massive overdose with very high initial acetaminophen concentrations 2
Special Populations Requiring Extended Treatment
Do NOT stop at 21 hours in these scenarios:
- Delayed presentation: Patients presenting >8-10 hours post-ingestion with evidence of toxicity 2
- Hepatotoxicity already present: Any patient with ALT/AST >1000 IU/L should continue NAC until transaminases are declining 2, 5
- Fulminant hepatic failure: Continue NAC and involve transplant hepatology immediately 2
- Repeated supratherapeutic ingestion (RSI): The Rumack-Matthew nomogram does not apply; treat based on acetaminophen levels and transaminases 1
- Extended-release formulations: May require prolonged monitoring and treatment 1
Common Pitfalls to Avoid
Don't rely solely on time: The 21-hour protocol is a minimum, not an automatic stop point. Always check labs before discontinuing 4, 5
Don't stop with detectable acetaminophen: Even low levels (10-20 mg/L) warrant continuation, as 26% of patients in one study received additional NAC solely for residual acetaminophen 6
Don't ignore rising transaminases: Even if <1000 IU/L, rising ALT/AST at 21 hours indicates ongoing hepatocellular injury requiring extended NAC 5
Don't use abbreviated protocols liberally: The 12-hour SNAP protocol and early-stop pathways are only validated for low-risk patients with normal transaminases and undetectable acetaminophen at 12 hours 3, 4
Don't forget high-risk factors: Chronic alcoholism, malnutrition, or CYP2E1-inducing drugs (isoniazid) may require treatment even with "non-toxic" nomogram levels 1
Practical Algorithm
At 20-21 hours, obtain:
- Acetaminophen level
- ALT, AST
- INR
- Clinical assessment
If ALL normal/negative → STOP NAC
If ANY abnormal → Continue NAC at 100 mg/kg over 16 hours and reassess
Repeat labs every 12-24 hours until:
- Acetaminophen undetectable
- Transaminases declining
- INR normalizing
- Patient clinically well
The evidence strongly supports that most patients with acute overdose treated early can safely stop NAC at 21 hours if laboratory and clinical criteria are met 2, 1, 5. However, extending treatment is low-risk and potentially life-saving when any doubt exists about ongoing toxicity 4, 7.